We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.50 | 4.86% | 97.00 | 90.00 | 100.00 | 95.00 | 92.50 | 92.50 | 18,552 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 24k | -17.01M | -0.2722 | -3.49 | 59.35M |
Hot Features
Premium
RNS Number:0130U
Celsis International PLC
08 January 2004
Celsis International plc
("the Company")
Holding in Company
Celsis International plc announces that it received notification on 8 January
2004 that, as at 5 January 2004, Barclays PLC had a notifiable interest in
3,447,128 ordinary shares representing 3.07 per cent. of the issued share
capital of the Company. None of the beneficial holders of the shares have
notifiable interests.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWUSRSBRARAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
